The following posters will be presented:
We are pleased to announce the presentation of our research results during this meeting:
- In the session “Male LUTS, Clinical and Basic science”, a podium presentation will be given on “Differences in the actions of the M3-antagonist tolterodine and the beta3-adrenoceptor agonist mirabegron on non-voiding activity in rats with partial outflow obstruction”, on August 27th from 11:00 to 12:30
- In the session “Clinical and Basic Neurology”, two presentations will be given on “Comparison of the effects of netupitant and tolterodine on overactive bladder induced by intravesical acetic acid infusion in anesthetized female guinea-pigs” and "Netupitant, a potent and highly selective NK1 receptor antagonist in the guinea-pig isolated urinary bladder: comparison with aprepitant" on August 26th from 11:00 to 12:30
More infosThe following posters will be presented:
To organize a meeting with our team, please contact us.
The following posters will be presented:
- Lluel P, Guerard M, Palea S, Julia-Guilloteau V. Duloxetine counteracts bladder overactivity induced by intravesical acetic acid in anesthetized female guinea-pigs through activation of 5-HT receptors.
- Lluel P, Chene G, Dubourdeau M, Vergnolle N, Palea S, Coelho AM. Increase in arachidonic acid metabolites in the urine of female rats with cyclophosphamide-induced cystitis.
UROsphere's top managers will be present during the meeting. If you wish to meet them, please contact us or contact our US office.
Following posters will be presented in different sessions:
- Deba A, Lluel P, Palea S. Functional evidence of β3-adrenoceptors (β3-AR) in female mouse isolated urinary bladder.
- Deba A, Palea S, Parini A, Lluel P. Differential gene expression in bladder hypertrophy following bladder outlet obstruction in mouse.
- Lluel P, Guilloteau V, Guerard M, Pietra C, Lovati E, Palea S. Netupitant, a new selective NK1 receptor antagonist, reverses acetic acid-induced bladder overactivity in anesthetized female guinea-pigs.
- Palea S, Gilles N, Guerard M, Lluel P. AdTx1, a new peptidic α1A-adrenoceptor antagonist: in vivo pharmacological characterization.
UROsphere's top management will be present during the meeting. If you wish to meet them, please
UROsphere will take part in the European Association of Urology's Annual Meeting and present scientific results on BPH research:
Gilles N, Lluel P, Rekik M, Guerard M, Palea S. AdTx1, a new peptidic α1-adrenoceptor antagonist with high affinity and selectivity for human α1A-adrenoceptor subtype: pharmacological characterization.
The company's top managers will also present the company's expertise to members of the Medicon Valley biotech cluster (in Sweden and Denmark) in March 2009.
To read the press release, click here .